INAB

IN8bio Inc. Common Stock (INAB)

Stock · NASDAQ · Health Care

$1.03as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$1.4
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Fundamentals

Market cap
$9.55M
P/E (trailing)
P/E (forward)
EPS (trailing)
Dividend yield
Beta
Avg. volume

IN8bio Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • INAB
    IN8bio Inc. Common Stock
    $1.03
    ▼ 0.48%
    Market cap $9.55MP/E
  • CRIS
    Curis Inc. Common Stock
    $1.49
    ▲ 2.76%
    Market cap $8.59MP/E
    $1.4$39
  • BCDA
    BioCardia Inc. Common Stock
    $1.16
    ▼ 0.85%
    Market cap $10.80MP/E
    $0.75$2.29
  • INTS
    Intensity Therapeutics Inc. Common stock
    $4.25
    ▲ 0.95%
    Market cap $11.49MP/E
    $3.51$43.5
  • AIM
    AIM ImmunoTech Inc. Common Stock
    $0.2558
    ▲ 2.32%
    Market cap $7.51MP/E
    $0.1901$2.89
  • VIVS
    VivoSim Labs Inc. Common Stock
    $0.29
    ▲ 0.00%
    Market cap $5.53MP/E
    $0.2625$5.3
  • PASG
    Passage Bio Inc. Common Stock
    $4.52
    ▲ 4.39%
    Market cap $14.11MP/E
    $3.29$20

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
434.8K
Disposed
724.6K

Institutional Ownership

March 31, 2026

Total shares held
3.66M
Total value held
$5.42M
Institutional holders
18
Top holders this quarter
  • Unknown944.3K
  • Unknown914.5K
  • Unknown724.6K
  • Unknown663.4K
  • Unknown167.8K
  • Unknown86.2K
  • Unknown43.6K
  • Unknown33.3K
  • Unknown24.0K
  • Unknown23.8K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.